Betnovate S-20g
Generic: Betamethasone/Salicylicby GlaxoSmithKline Pharmaceuticals Ltd

Select pack size
Similar medicines
View allAbout Betnovate S-20g
Betnovate-S is a steroid ointment for thick, scaly skin, made in India by GlaxoSmithKline Pharmaceuticals (GSK India). Each gram contains betamethasone valerate equivalent to 0.1% w/w betamethasone, a potent corticosteroid, and 3% w/w salicylic acid, which softens and lifts scale, in a greasy paraffin base. It comes in a 20 g tube. We sell it in packs of 3, 6 and 12 tubes, from $3.96 a tube in the 12 pack before shipping.
Read three things before you buy. First, this is a strong steroid for diagnosed psoriasis, chronic eczema and similar dry, scaly skin conditions, used in short courses. It is not for itching without inflammation, rashes of unknown cause, acne, ringworm or other fungal infections, or for lightening skin. Second, its Indian label says it must not be used on fungal, viral or bacterial skin infections, acne, rosacea, a rash around the mouth (perioral dermatitis), or on itching of the genital or anal area, and UK labels for the same steroid limit use on the face and in children to 5 days. Third, it is a prescription medicine in India, and the same steroid is prescription only in the US, UK, Australia and Canada. Use it only if a doctor has diagnosed your skin condition.
Betnovate-S at a glance
| Active ingredients | Betamethasone valerate equivalent to betamethasone 0.1% w/w (a potent corticosteroid) and salicylic acid 3% w/w (a keratolytic, which loosens scale), in a greasy base of liquid and white soft paraffin |
| Brand and maker | Betnovate-S, by GlaxoSmithKline Pharmaceuticals Limited, India (GSK India prescribing information; PharmEasy, Apollo Pharmacy and Truemeds listings) |
| Form | Ointment in a 20 g aluminium tube |
| Used for | Subacute and chronic hyperkeratotic and dry skin diseases that respond to topical steroids, including psoriasis (excluding widespread plaque psoriasis), thickened skin of the palms and soles, chronic eczema, atopic and seborrhoeic eczema, lichen planus and lichen simplex, and ichthyosis (GSK India label) |
| Regulatory status | This Indian pack is not registered with the FDA, MHRA, TGA or Health Canada. We found no betamethasone valerate with salicylic acid product approved in the US, listed on the UK emc or in Health Canada's drug database. A related combination, Diprosalic (betamethasone dipropionate with salicylic acid), is licensed in the UK and Canada. |
| Usual use | A thin layer on the affected area twice daily, morning and evening; once daily is enough in some conditions. Reassess if no improvement within 4 weeks (GSK India label). |
| Prescription | Prescription medicine in India (Apollo Pharmacy, Truemeds). Betamethasone skin products are prescription only in the US, UK, Australia and Canada. |
| Storage | Protected from light, not above 25 °C; do not freeze (GSK India label; PharmEasy and Truemeds listings) |
| Packs | 3, 6 and 12 tubes of 20 g |
| Price per tube | $4.58 (3 pack) down to $3.96 (12 pack), before shipping |
| Delivery | 7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149 |
Price per tube
Prices below are as of October 2026; the pack selector shows the current price.
| Pack | Price | Per tube | Shipping | Per tube with shipping |
|---|---|---|---|---|
| 3 tubes (60 g) | $13.75 | $4.58 | $25 | $12.92 |
| 6 tubes (120 g) | $25.00 | $4.17 | $25 | $8.33 |
| 12 tubes (240 g) | $47.50 | $3.96 | $25 | $6.04 |
Every pack is under the $149 free shipping threshold, so each order pays $25 shipping. Per gram with shipping, the ointment costs $0.65 in the 3 pack and $0.30 in the 12 pack ($0.23 and $0.20 before shipping).
Be clear about how much you need. The labels give no amount in grams for each application. One fingertip unit, a line of ointment from the tip of an adult index finger to the first crease, is about 0.5 g and covers an area about the size of two adult hands laid flat (Guy's and St Thomas' NHS guidance). For a patch that size, twice daily use is about 1 g a day, so one 20 g tube lasts about 20 days and a 4 week course uses about 28 g (our arithmetic, not a label figure). Even our smallest pack, 60 g, holds more than that course. The larger packs are not a reason to keep going: this ointment is for short courses, and the GSK India label says the condition needs reassessment if it has not improved within 4 weeks.
Compared with UK and US options
| Betnovate-S (India) | Diprosalic Ointment (UK, Canada) | US generic betamethasone valerate 0.1% ointment | |
|---|---|---|---|
| Steroid | Betamethasone valerate, equivalent to 0.1% betamethasone | Betamethasone dipropionate, equivalent to 0.05% betamethasone | Betamethasone valerate, equivalent to 0.1% betamethasone |
| Salicylic acid | 3% | 3% | None |
| Potency class | Potent (Group III) in UK classification for both betamethasone esters; UK packs are labelled "strong steroid" | ||
| Status | Not registered with the FDA, MHRA, TGA or Health Canada | UK licence PL 00025/0570 (Organon); Health Canada DIN 00578436, marketed | FDA approved, Rx only |
| Cost per gram | $0.20 to $0.23 before shipping ($0.30 to $0.65 with shipping) | Not checked | $0.48 to $0.55 (NADAC) |
The two combinations are not the same product: they use different forms of betamethasone at different strengths, and we found no study comparing them. We use the UK Diprosalic label below where it covers the salicylic acid part, because no UK, US or Canadian regulator has a label for Betnovate-S itself. NADAC is the average price US pharmacies pay, not a retail price; the figures are per gram for generic betamethasone valerate 0.1% ointment in 15 g and 45 g tubes, effective 21 October 2026. In the US, salicylic acid 1.8% to 3% products for psoriasis can be sold without a prescription under the FDA's over the counter rules, but there is no approved product that combines it with betamethasone. If you are in the US and have a prescription, compare pharmacy cash prices for the generic betamethasone valerate ointment (which has no salicylic acid) before you order from abroad: it is FDA approved, and a 15 g tube costs a US pharmacy about $8.30.
Other steroid and psoriasis products we list
| Product | What it contains |
|---|---|
| Betnovate 20g | Betamethasone on its own, without salicylic acid (our listing) |
| Eclospan S Ointment | Clobetasol with salicylic acid (our listing). Clobetasol is a very potent steroid, a step above betamethasone. |
| Propysalic NF Ointment | Clobetasol with salicylic acid (our listing), also very potent |
| Pasitrex Ointment | Calcipotriol, a vitamin D analogue, with no steroid (our listing) |
| Salicylix SF 6 Ointment | Salicylic acid on its own, with no steroid (our listing) |
For psoriasis of the trunk and limbs in adults, the UK NICE guideline's first treatment is a potent steroid once daily plus a vitamin D analogue such as calcipotriol once daily, applied separately (one in the morning, the other in the evening), for up to 4 weeks (recommendation 1.3.2.1). For scalp psoriasis that a potent steroid has not controlled after 4 weeks, NICE suggests considering products such as salicylic acid to remove stuck-on scale before the steroid (1.3.3.3). A doctor will decide which of these suits your skin; do not step up to a clobetasol product on your own.
How to use Betnovate-S
- Use it only on skin a doctor has diagnosed, for the condition it was prescribed for. It is "For external use only" (GSK India label).
- Apply it thinly to the entire affected area, twice daily, morning and evening, unless your doctor says otherwise. In some skin disorders once daily is enough (GSK India label, section 4.2). Rub it in gently. Wash your hands afterwards, unless you are treating your hands (UK Betnovate leaflet).
- If you also use a moisturiser (emollient), leave enough time for the ointment to absorb first (GSK India label).
- Do not cover the treated skin with bandages, plasters, cling film or tight clothing. The UK Diprosalic label says "Occlusion must not be used", because salicylic acid may then increase how much steroid is absorbed; Apollo Pharmacy and Truemeds give the same advice for Betnovate-S. The GSK India label does not forbid covering, but lists occlusive dressings and skin folds as risk factors for absorbing more steroid. Plain Betnovate ointment in the UK allows overnight covering of thick plaques, but for a salicylic acid combination we follow the Diprosalic rule and advise against any covering (our advice).
- Keep it out of the eyes, nose and mouth. If it is used on the eyelids, the ointment must not get into the eye: repeated exposure might cause eye irritation, cataract and glaucoma (GSK India label).
- Do not use it on large areas of skin or for longer than your doctor advises. Salicylic acid absorbed from extensive use can cause salicylate poisoning (salicylism) (GSK India label, section 4.4).
- If your skin has not improved within 4 weeks, go back to your doctor (GSK India label). The UK Diprosalic label goes further: it recommends prescribing for two weeks and reviewing treatment then, and says the maximum weekly amount should not exceed 60 g.
- Once the skin is under control, ask your doctor how to step down. The UK Betnovate label says treatment should be gradually discontinued once control is achieved, with an emollient continued, and that the condition can rebound if it is stopped abruptly. The GSK India label says that if signs of steroid excess appear, it should be withdrawn gradually, by using it less often or changing to a weaker steroid.
- The ointment contains paraffin. Do not smoke or go near naked flames while using it: clothing, bedding and dressings that have touched it burn more easily, and washing may not remove it fully (GSK India label).
Short courses only: face, skin folds and psoriasis
Betamethasone valerate is classed as a potent steroid in the UK, and UK packs carry the words "strong steroid" (UK Betnovate and Diprosalic labels). The MHRA asks prescribers to use the lowest potency that works, and to tell patients how long to use it, especially on sensitive areas such as the face and genitals. Where you use it matters:
- Face. The GSK India label says "Prolonged application to the face is undesirable as this area is more susceptible to atrophic changes." The UK Betnovate and Diprosalic labels limit courses on the face to 5 days. For psoriasis, NICE says: "Do not use potent or very potent corticosteroids on the face, flexures or genitals" (1.3.4.4). PharmEasy says it should not be used on the face unless your doctor prescribes it.
- Groin, armpits and other skin folds. Skin folds act like a covering and increase absorption (GSK India label, section 4.4). Apollo Pharmacy says not to apply it to the face, groin, underarms or skin folds unless your doctor directs it. Itching of the genital or anal area is a contraindication (GSK India label).
- Psoriasis. The GSK India label covers psoriasis but excludes widespread plaque psoriasis, and warns that steroids in psoriasis can lead to rebound relapses, tolerance, generalised pustular psoriasis and toxicity through damaged skin, so "careful patient supervision is important". NICE says not to use a potent steroid continuously at any site for longer than 8 weeks, and to aim for a break of 4 weeks between courses (1.3.1.14, 1.3.1.11).
- Large areas. NICE warns that continuous potent steroid use on extensive psoriasis (for example more than 10% of the body surface) can cause systemic side effects (1.3.1.10). On large areas, the salicylic acid adds its own risk of salicylism.
Long use of a potent steroid can also cause problems when you stop. The MHRA reviewed topical steroid withdrawal reactions in 2021 and again in 2024: after long-term use (generally 6 months or more) of moderate or stronger steroids, some people develop intense redness, stinging and burning that can spread beyond the area treated. The exact frequency cannot be determined, but the MHRA estimates the reactions are rare. Its advice to patients: if your skin worsens within 2 weeks of stopping a topical steroid, do not start treatment again without consulting your doctor, unless they have previously advised you to.
Not a fairness cream, not for ringworm
Steroid creams are widely misused in India, and the two most common misuses are exactly what this ointment must not be used for:
- Fungal infections (ringworm, jock itch). Fungal skin infection is a contraindication on the GSK India label, and PharmEasy says Betnovate-S "should not be used for the treatment of ringworm". A steroid can make a fungal rash look better for a while while the infection spreads. In a study across 13 Indian centres, 50.9% of people with chronic or recurrent ringworm had misused topical steroid creams (Shenoy 2022, PMID 34378240), and an Indian dermatology expert group "strongly discouraged" any topical steroid for ringworm, alone or in combination (Rengasamy 2020, PMID 32832435). If your rash is red, ring shaped, itchy and spreading, see a doctor for an antifungal.
- Skin lightening. In a 12 centre Indian study of 433 people using steroid creams on the face, use as a fairness or general purpose cream or aftershave was the most common reason (29%), and 90.5% had side effects, most often acne or worsening acne (Saraswat 2011, PMID 21393945). Betnovate-S does not lighten skin, and steroids on the face cause thinning, redness and visible blood vessels.
- Acne and rosacea. Both are contraindications on the GSK India label; PharmEasy says using it on acne "makes your acne worse".
India moved betamethasone and 13 other topical steroids into Schedule H, the list of medicines to be sold only on prescription, in March 2018, after complaints that steroid creams were being sold without medical guidance (draft notification G.S.R. 1357(E), 1 November 2017; final rule as reported by Medical Dialogues and Down To Earth).
Extra care for some groups
- Babies under 1 year: Betnovate-S is contraindicated (GSK India label), including for nappy rash.
- Children over 1 year: children absorb more steroid through the skin and are more likely to have side effects, and in general need shorter courses and weaker steroids (GSK India label). Long-term continuous use under 12 years should be avoided where possible, because adrenal suppression can occur. UK labels for Betnovate and Diprosalic limit courses in children to 5 days. Use it in a child only if a doctor prescribes it, and never under a nappy (UK Diprosalic leaflet).
- Pregnancy: there are limited data. Steroids applied to the skin of pregnant animals can cause abnormalities of foetal development; the GSK India label says use in pregnancy should only be considered if the expected benefit to the mother outweighs the risk to the foetus, using the minimum quantity for the minimum duration.
- Breastfeeding: safe use has not been established. If used, do not apply it to the breasts, so the baby does not swallow it (GSK India label).
- Older people, and kidney or liver problems: elimination may be slower if the steroid is absorbed, so use the minimum quantity for the shortest time (GSK India label).
- Medicines that block CYP3A4, such as ritonavir or itraconazole, can raise the amount of steroid in the body (GSK India label, section 4.5). Tell your doctor about all your medicines.
- Leg ulcers: using topical steroids on the skin around chronic leg ulcers may bring more allergic reactions and infection (UK Betnovate label). Ulcerated skin is a contraindication on the GSK India label.
Side effects
The GSK India label lists these reactions for betamethasone valerate from post-marketing reports:
| How often | Reaction |
|---|---|
| Common (1 in 100 to 1 in 10) | Itching; local skin burning or skin pain |
| Very rare (under 1 in 10,000) | Skin thinning, wrinkling and dryness; stretch marks; visible small blood vessels; pigment changes; extra hair growth; allergic contact dermatitis, redness, rash, hives; pustular psoriasis; worsening of the condition; opportunistic infection; local hypersensitivity; application site irritation or pain |
| Very rare, from absorption into the body | Adrenal (HPA axis) suppression; Cushingoid features such as moon face and central obesity; delayed weight gain or growth in children; osteoporosis; glaucoma; cataract; raised blood sugar or sugar in the urine; high blood pressure; weight gain; lower natural cortisol levels; hair loss (alopecia) and hair breakage (trichorrhexis) |
From GSK India prescribing information, section 4.8. For the salicylic acid, the same label adds dryness, skin irritation and unwanted scaling, and says salicylic acid may increase absorption of the steroid. The UK Diprosalic label says local and systemic toxicity is common after long continuous use on large areas of damaged skin, in skin folds or under plastic covering. If irritation is troublesome, stop and speak to a doctor.
When to stop and get help
- Dizziness, fainting or feeling very weak, especially after long use on large areas or after stopping suddenly: get urgent medical help. The MHRA says adrenal suppression from overuse of topical steroids causes low blood pressure, dizziness and fainting, is a serious, life-threatening condition that needs urgent treatment, and that stopping the steroid suddenly is dangerous if adrenal suppression is present. Tell the emergency staff what you used, how much and for how long.
- Feeling or being sick, or ringing in the ears, after using it on large areas or for a long time: stop and see a doctor straight away. The UK Diprosalic leaflet lists these as signs of using too much; they can come from salicylic acid absorbed through the skin. In one published case, an 80 year old woman treated with salicylate ointments for widespread red skin became confused after 6 days and needed intensive care (Brubacher 1996, PMID 8699558).
- Swelling of the face, lips, tongue or throat, trouble breathing, or widespread hives: get urgent medical help. True allergy to the ointment is very rare; this is general safety advice.
- Blurred vision or other changes in your eyesight: contact your doctor immediately (UK Diprosalic leaflet). The GSK India label says causes to check for include cataract, glaucoma and a retinal condition called central serous chorioretinopathy.
- A rash that spreads, becomes more inflamed, oozes or develops pus while you use it: stop and see a doctor. The GSK India label says any spread of infection requires stopping the steroid and treating the infection.
- Redness, burning or stinging that spreads beyond the treated area within days to weeks of stopping: see a doctor before you restart (MHRA, UK labels).
- Moon face, weight gain around the middle, stretch marks or slow wound healing after long use: see a doctor (signs of steroid excess listed in the GSK India label and the MHRA 2024 update). Do not stop a long course suddenly without advice.
Who should not use Betnovate-S
Never use it for these conditions, all contraindications on the GSK India label (section 4.3):
- Allergy to betamethasone, salicylic acid or any ingredient of the ointment
- Skin infections caused by fungi (such as ringworm), viruses or bacteria (the UK Diprosalic label names herpes simplex, which causes cold sores, and chickenpox)
- Rosacea, acne vulgaris and perioral dermatitis (a rash around the mouth)
- Itching without inflammation, and itching around the anus or genitals
- Ulcerated skin
- Any skin condition in a baby under 1 year, including dermatitis and nappy rash
Avoid or limit it in these situations (GSK India and UK labels): long or repeated use on the face; skin folds and the groin; large areas of skin; under bandages or other coverings; broken skin; long continuous use in children; and widespread plaque psoriasis, which the label's indication excludes. Talk to a doctor first if you are pregnant or breastfeeding, or take ritonavir, itraconazole or other medicines that block CYP3A4. Truemeds also advises people with diabetes or circulation problems to watch the treated area closely. Keep it out of reach of children.
Prescription and legal status
Betnovate-S is a prescription medicine in India: Apollo Pharmacy lists it as a prescription medicine and Truemeds says a prescription is required, and its prescribing information is "For the use only of Registered Medical Practitioners". Betamethasone skin products are prescription only in the US (the generic ointment label is "Rx only"), the UK (Betnovate and Diprosalic are prescription only medicines, POM), Australia (betamethasone is Schedule 4, Prescription Only Medicine, in the Poisons Standard) and Canada (Betaderm 0.1% ointment and Diprosalic are listed as prescription in Health Canada's database). We did not confirm whether any betamethasone with salicylic acid product is on the Australian register. This Indian pack is not registered with the FDA, the MHRA, the TGA or Health Canada, and in the US the FDA says personal importation of unapproved medicines is illegal in most circumstances. See a doctor before you start, and check the rules where you live.
Buying genuine Betnovate-S
The MHRA warns: "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have." It advises UK buyers: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo". That warning covers Betnovate-S, which is not authorised in the UK. When your order arrives, check that the carton and tube name GlaxoSmithKline and Betnovate-S, show betamethasone 0.1% and salicylic acid 3%, a batch number and an expiry date, and that the tube is sealed. These checks cannot prove a tube is genuine, because counterfeiters copy packaging. If a tube causes unusual symptoms, stop using it, seek medical advice, and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us. Store it below 25 °C, protected from light, and do not freeze it.
Delivery
We ship Betnovate-S to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days to most countries. Shipping costs a flat $25 on orders under $149 and is free from $149. See our shipping page and refund policy.
Sources
- BETNOVATE-S (betamethasone valerate and salicylic acid skin ointment) prescribing information, sections 2, 4.1 to 4.9, 6, 8.3 and 8.4. GlaxoSmithKline Pharmaceuticals Limited, India, version BEVS/PI/IN/2025/01, revised 3 April 2025. GSK India
- Indian listings for Betnovate-S Ointment 20 g (composition, maker, form, prescription status, storage, warnings): PharmEasy, Apollo Pharmacy and Truemeds, checked 21 October 2026.
- Diprosalic Ointment (betamethasone dipropionate 0.05%, salicylic acid 3%) SmPC, sections 4.2, 4.3, 4.4, 4.8, 4.9 and 5.1, and patient leaflet. Organon Pharma (UK) Limited, PL 00025/0570, text revised 12 February 2025. emc
- Betnovate Ointment (betamethasone valerate 0.122%) SmPC, sections 4.1 to 4.4 and 5.1, and patient leaflet. GlaxoSmithKline UK, updated 18 July 2024. emc
- Betamethasone valerate cream, ointment and lotion USP 0.1%, US prescribing information. E. Fougera and Co., DailyMed setid 0b386ccc-a2d4-4d18-a2d7-e46ff894c674, version 10, February 2026.
- MHRA Drug Safety Update. Topical corticosteroids: information on the risk of topical steroid withdrawal reactions, 15 September 2021; and Topical steroids: introduction of new labelling and a reminder of the possibility of severe side effects, including topical steroid withdrawal reactions, May 2024. GOV.UK.
- National Institute for Health and Care Excellence. Psoriasis: assessment and management (CG153), recommendations 1.3.1.10 to 1.3.1.15, 1.3.2.1, 1.3.3.3 and 1.3.4.4. NICE
- Guy's and St Thomas' NHS Foundation Trust. Topical steroids (fingertip units). Long CC, Finlay AY. The finger-tip unit: a new practical measure. Clin Exp Dermatol 1991. PMID 1806320.
- Saraswat A, et al. Topical corticosteroid abuse on the face: a prospective, multicenter study of dermatology outpatients. Indian J Dermatol Venereol Leprol 2011. PMID 21393945.
- Jha AK, et al. Misuse of topical corticosteroids on the face: a cross-sectional study among dermatology outpatients. Indian Dermatol Online J 2016. PMID 27559498.
- Shenoy MM, et al. A multicentric clinical and epidemiological study of chronic and recurrent dermatophytosis in India. Mycoses 2022. PMID 34378240.
- Rengasamy M, et al. IADVL Task Force against Recalcitrant Tinea (ITART) consensus on the management of glabrous tinea (INTACT). Indian Dermatol Online J 2020. PMID 32832435.
- Brubacher JR, Hoffman RS. Salicylism from topical salicylates: review of the literature. J Toxicol Clin Toxicol 1996. PMID 8699558. Madan RK, Levitt J. A review of toxicity from topical salicylic acid preparations. J Am Acad Dermatol 2014. PMID 24472429.
- Ministry of Health and Family Welfare (India). Draft notification G.S.R. 1357(E), 1 November 2017 (Schedule H entries for 14 topical steroids, including betamethasone); final notification of 23 March 2018 as reported by Medical Dialogues and Down To Earth, April 2018.
- FDA Drugs@FDA (openFDA), betamethasone valerate and salicylic acid products; 21 CFR 358.710 (over the counter psoriasis ingredients); UK emc search for betamethasone with salicylic acid; Health Canada Drug Product Database (Diprosalic DIN 00578436, Betaderm ointment 0.1% DIN 00716650); Therapeutic Goods (Poisons Standard June 2026) Instrument 2026, betamethasone. Checked 21 October 2026.
- Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC), betamethasone valerate 0.1% ointment, effective 21 October 2026. data.medicaid.gov
- MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK.
- US Food and Drug Administration. Personal Importation. FDA
This page is for information and is not medical advice. Betnovate-S contains a potent steroid and is a prescription medicine in India; talk to a doctor before using it.
Frequently asked questions
What is Betnovate-S Ointment?
Betnovate-S is a steroid ointment made in India by GlaxoSmithKline Pharmaceuticals (GSK India). Each gram contains betamethasone valerate equivalent to 0.1% w/w betamethasone, a potent corticosteroid, and 3% w/w salicylic acid, which loosens scale. It comes in a 20 g tube and is used for psoriasis, chronic eczema and other dry, thick, scaly skin conditions that respond to steroids.
Is Betnovate-S the same as Betnovate or Diprosalic?
No. Plain Betnovate ointment contains the same steroid without salicylic acid. Diprosalic, licensed in the UK and Canada, combines salicylic acid 3% with a different form of betamethasone (dipropionate, equivalent to 0.05% betamethasone). We found no study comparing Betnovate-S with Diprosalic, and no betamethasone valerate with salicylic acid product approved in the US, listed on the UK emc or in Health Canada's drug database.
How much does Betnovate-S cost per tube?
As of October 2026, the 3 pack works out at $4.58 a tube and the 12 pack at $3.96 a tube before shipping. Shipping is a flat $25 on orders under $149, so a 3 pack costs $38.75 with shipping ($12.92 a tube). The pack selector shows the current price.
How do I use Betnovate-S?
Apply a thin layer to the entire affected area twice daily, morning and evening, unless your doctor says otherwise; once daily is enough in some conditions (GSK India label). Do not cover it with bandages or plastic: the UK label for Diprosalic, a related betamethasone and salicylic acid ointment, says occlusion must not be used, and the Indian listings say not to cover it. Keep it out of the eyes, and do not smoke or go near naked flames, because the paraffin base makes fabric burn more easily.
How long can I use it?
Only for short courses agreed with your doctor. The GSK India label says reassess if there is no improvement within 4 weeks; the UK Diprosalic label recommends review after two weeks and no more than 60 g a week. For psoriasis, NICE says not to use a potent steroid continuously at any site for longer than 8 weeks, and to aim for a 4 week break between courses. Ask your doctor how to step down rather than stopping a long course suddenly.
Can I use Betnovate-S on my face or groin?
Not unless a doctor tells you to. The GSK India label says prolonged use on the face is undesirable because facial skin thins easily, and UK labels for betamethasone limit courses on the face to 5 days. For psoriasis, NICE says not to use potent steroids on the face, flexures or genitals. Skin folds increase absorption, and itching around the genitals or anus is a contraindication.
Can I use it for ringworm, a fungal rash or to lighten my skin?
No. Fungal, viral and bacterial skin infections are contraindications on the GSK India label, and PharmEasy says it should not be used for ringworm. A steroid can hide a fungal rash while it spreads; Indian dermatologists strongly discourage any steroid cream for ringworm. It does not lighten skin, and steroid use on the face causes thinning, redness and acne. Acne and rosacea are also contraindications.
What are the side effects?
The GSK India label lists itching and local burning or skin pain as common. Very rare effects include skin thinning, stretch marks, visible small blood vessels, pigment changes, pustular psoriasis and, if enough is absorbed, adrenal suppression, Cushingoid features, raised blood sugar, cataract and glaucoma. Salicylic acid can cause dryness and irritation, and extensive use can cause salicylate poisoning (GSK India label), with sickness or ringing in the ears (UK Diprosalic leaflet).
Who should not use Betnovate-S?
Do not use it if you are allergic to any ingredient, on skin infections, acne, rosacea or a rash around the mouth, on ulcerated skin, for itching without inflammation or genital or anal itching, or on any skin condition in a baby under 1 year (GSK India label). Children over 1 need a doctor's prescription and short courses. Ask a doctor first if you are pregnant or breastfeeding, or take ritonavir or itraconazole.
Do I need a prescription for Betnovate-S?
Yes. It is a prescription medicine in India, and India placed betamethasone and other topical steroids in Schedule H in 2018. Betamethasone skin products are prescription only in the US, UK, Australia and Canada. This Indian pack is not registered with the FDA, MHRA, TGA or Health Canada, and the FDA says personal importation of unapproved medicines is illegal in most circumstances.
How long does delivery take and how should I store it?
Delivery takes 7 to 14 business days to the US, UK, Australia and Canada, in plain packaging with tracking. Shipping is $25 under $149 and free from $149. Store the tube below 25 °C, protected from light, and do not freeze it (GSK India label).
Medical References
- 1.DailyMed (U.S. National Library of Medicine)
- 2.PubMed (NCBI) (PMID: 3888490) — 1985
- 3.PubMed (NCBI) (PMID: 724339) — 1978
- 4.PubMed (NCBI) (PMID: 3905333) — 1985
- 5.PubMed (NCBI) (PMID: 2178849) — 1990
- 6.PubMed (NCBI) (PMID: 24472429) — 2014
- 7.PubMed (NCBI) (PMID: 32243212) — 2020
- 8.PubMed (NCBI) (PMID: 34417633) — 2022
- 9.PubMed (NCBI) (PMID: 29411351) — 2018
Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA
Related articles
Customer Reviews
No reviews yet. Bought Betnovate S-20g? Tell other buyers how it went.







